-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanoform Partners With Global CDMO for GMP Manufacturing of Ultra-High-Concentration Biologics

PUBT·11/17/2026 06:13:01
Diffusion vocale
Nanoform Partners With Global CDMO for GMP Manufacturing of Ultra-High-Concentration Biologics
  • Nanoform signed an agreement with a global contract manufacturer to implement its biologics technology at a German facility.
  • The partners will establish a dedicated production line for aseptic manufacturing of ultra-high-concentration biologics.
  • GMP readiness is targeted for the second half of 2027 to support a planned first customer clinical trial of a subcutaneous biologic.
  • The agreement has no immediate material financial effect.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanoform Finland plc published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.